How to sell to Founders at Biotech companies
Founders in the biotech industry focus on securing funding for R&D projects, with success measured by the amount raised in each funding round. They are likely to respond to outreach that demonstrates a clear understanding of their clinical trial challenges and the regulatory landscape they navigate, as these are critical to their growth and sustainability.
What actually hurts
- delays in clinical trial approvals
- high costs of regulatory compliance
- difficulty in securing funding
- managing investor expectations
The playbook
- 01
Identify recent funding announcements
Search for biotech companies that have recently secured funding through platforms like Crunchbase or PitchBook. Focus on firms that have raised between $5M to $20M, as they are likely to be in a growth phase and open to new partnerships.
- 02
Highlight regulatory hurdles in outreach
Craft your message to address common regulatory challenges in clinical trials that these founders face. Mention specific regulations like FDA approval processes, as demonstrating knowledge of these hurdles can capture their attention.
- 03
Use specific clinical trial milestones
Reference recent milestones achieved by the prospect, such as successful Phase I trials. This shows you are aware of their progress and can provide relevant solutions that align with their current objectives.
- 04
Anticipate objections about ROI
Prepare to address common objections regarding return on investment, particularly around the costs of compliance and trial management. Offer insights on how your solution can mitigate these costs and enhance efficiency.
- 05
Follow up after funding announcements
If you haven't received a response within a week of your initial outreach, send a follow-up email referencing the recent funding announcement. Timing your follow-up around their funding news can help increase your chances of booking a call.
Subject lines that fit
- Navigating clinical trial challenges
- Funding insights for biotech founders
- Streamlining regulatory compliance
Questions
- Why do biotech founders ignore cold outreach?
- Biotech founders often ignore cold outreach due to the overwhelming number of emails they receive. Many prioritize communications that directly relate to their current projects or funding needs, making it crucial for sellers to demonstrate immediate relevance in their outreach.
- What are the key concerns of biotech founders?
- Biotech founders are primarily concerned with securing funding, navigating regulatory challenges, and achieving clinical milestones. They need to ensure their projects are not only scientifically viable but also financially sustainable, which drives their decision-making process.
- How can I effectively reach biotech founders?
- To effectively reach biotech founders, tailor your outreach to address specific industry challenges, such as regulatory hurdles or funding strategies. Demonstrating a deep understanding of their operational landscape can significantly increase your chances of engagement.
- What factors influence a biotech founder's decision-making?
- A biotech founder's decision-making is influenced by factors such as the potential return on investment, regulatory compliance costs, and the urgency of clinical trial timelines. Solutions that can alleviate these concerns are more likely to resonate with them.
Or have it run itself
SoloRiff does every step above on its own — finds the companies, finds the people, writes each of them individually, and handles the replies. Drop your URL and watch it work before you sign up for anything.
Try it on your site